Article Versions Notes

Haist M, Stege H, Lang BM, Tsochataridou A, Salzmann M, Mohr P, Schadendorf D, Ugurel S, Placke J-M, Weichenthal M, et al. Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry. Cancers. 2022; 14(22):5543. https://doi.org/10.3390/cancers14225543

Haist, Maximilian, Henner Stege, Berenice Mareen Lang, Aikaterini Tsochataridou, Martin Salzmann, Peter Mohr, Dirk Schadendorf, Selma Ugurel, Jan-Malte Placke, Michael Weichenthal, and et al. 2022. "Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry" Cancers 14, no. 22: 5543. https://doi.org/10.3390/cancers14225543

Haist, M., Stege, H., Lang, B. M., Tsochataridou, A., Salzmann, M., Mohr, P., Schadendorf, D., Ugurel, S., Placke, J.-M., Weichenthal, M., Gutzmer, R., Leiter, U., Kaatz, M., Haferkamp, S., Berking, C., Heppt, M., Tschechne, B., Schummer, P., Gebhardt, C., ... Loquai, C. (2022). Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry. Cancers, 14(22), 5543. https://doi.org/10.3390/cancers14225543